NEOPLASMA
Zoznam článkov
Volume 64, 2017, No. 4
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Obsah:
- KOZICS, K. - SRANCIKOVA, A. - Sedlackova, E. - HORVÁTHOVÁ, E. - MELUSOVA, M. - Melus, V. - KRAJČOVIČOVÁ, Z. - SRAMKOVA, M.: Antioxidant potential of essential oil from Lavandula angustifolia in in vitro and ex vivo cultured liver cells. (s. 485)
- LI, C. - Kuang, L. - Zhu, B. - CHEN, J. - WANG, X. - Huang, X.: Identification of prognostic risk factors of acute lymphoblastic leukemia based on mRNA expression profiling. (s. 494)
- Qin, X. - WANG, Y. - LI, J. - XIAO, Y. - LIU, Z.: NFAT5 inhibits invasion and promotes apoptosis in hepatocellular carcinoma associated with osmolality. (s. 502)
- ZHANG, X. - SHI, C. - Yue, G. - GUO, H. - Fu, X. - LI, X. - LI, L. - WANG, X. - LI, Z. - Chang, Y. - ZHANG, M. - CHEN, Q.: The Effects of Lentivirus-mediated shRNA Interference Targeting Mcl-1 on Growth of NK/T-cell Lymphoma. (s. 511)
- Cai, C. - ZHANG, H. - Ou, Y. - Jiang, Y. - Zhong, D. - Qi, H. - Dang, Q.: Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway. (s. 518)
- Hou, X. - Sun, X. - YU, Y. - Zhao, H. - Yang, Z. - WANG, X. - Cao, X.: miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1. (s. 526)
- Shi, L. - He, C. - LI, Z. - WANG, Z. - Zhang, Q.: FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α. (s. 535)
- WANG, Y. - CHEN, J. - CHEN, X. - Jiang, F. - Sun, Y. - PAN, Y. - Zhang, W. - Zhang, J.: MiR-34a suppresses HNSCC growth through modulating cell cycle arrest and senescence. (s. 543)
- ZHANG, Y. - GUO, Y. - YANG, C. - ZHANG, S. - ZHU, X. - CAO, L. - Nie, W. - YU, H.: MicroRNA-300 targets hypoxia inducible factor-3 alpha to inhibit tumorigenesis of human non-small cell lung cancer. (s. 554)
- WENG, L. - WANG, G. - YAO, H. - YU, M. - Lin, J.: Epigallocatechin gallate inhibits the growth of salivary adenoid cystic carcinoma cells via the EGFR/Erk signal transduction pathway and the mitochondria apoptosis pathway. (s. 563)
- Dostalova Merkerova, M. - Hrustincova, A. - Krejcik, Z. - VOTAVOVA, H. - Ratajova, E. - ČERMÁK, J. - BELICKOVA, M.: Microarray profiling defines circulating microRNAs associated with myelodysplastic syndromes. (s. 571)
- Zang, Y. - WANG, T. - Pan, J. - Gao, F.: miR-215 promotes cell migration and invasion of gastric cancer cell lines by targeting FOXO1. (s. 579)
- LI, H. - YUAN, S. - HAN, Z. - HUANG, J. - Cui, L. - JIANG, C. - ZHANG, Y.: Prognostic significance of the tumor-stroma ratio in gallbladder cancer. (s. 588)
- YU, Y. - LI, N. - YUN, Z. - NIU, Y. - XU, J. - LIU, Z. - LIU, T. - WANG, R. - YU, K.: Preoperative mean platelet volume and platelet distribution associated with thyroid cancer. (s. 594)
- Głowacki, G. - MAJEWSKI, W. - WOJCIESZEK, P. - GRABINSKA, K. - WOZNIAK, G. - MISZCZYK, L.: Ultrahypofractionated CyberKnifeTM based stereotactic radiotherapy versus conventional radiotherapy in patients with prostate cancer – acute toxicity evaluation in two phase II prospective studies. (s. 599)
- FIALA, O. - Hosek, P. - PEŠEK, M. - FINEK, J. - RACEK, J. - BUCHLER, T. - Poprach, A. - Hejduk, K. - Chloupkova, R. - SOREJS, O. - Ecksteinova, M. - Vitovec, M. - Cizkova, K. - KUCERA, R. - TOPOLCAN, O.: Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed. (s. 605)
- WANG, W. - LIANG, M. - MA, G. - LI, L. - ZHOU, W. - XIA, T. - XIE, H. - WANG, S.: Plasma cell-free DNA integrity plus circulating tumor cells: a potential biomarker of no distant metastasis breast cancer. (s. 611)
- Tu, C. - ZHU, Y. - Jiang, B. - HE, W. - Jin, C.: Correlation between circulating tumor cells EGFR expression and T cell subsets in advanced non-small cell lung cancer patients after tyrosine kinase inhibitor treatment. (s. 619)
- BAI, X. - MAO, L. - CHI, Z. - SHENG, X. - CUI, C. - KONG, Y. - DAI, J. - WANG, X. - LI, S. - TANG, B. - LIAN, B. - ZHOU, L. - YAN, X. - GUO, J. - SI, L.: BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma. (s. 626)
- GIAGINIS, C. - Karandrea, D. - ALEXANDROU, P. - Giannopoulou, I. - Tsourouflis, G. - Troungos, C. - Danas, E. - Keramopoulos, A. - PATSOURIS, E. - Nakopoulou, L. - THEOCHARIS, S.: High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma. (s. 633)